Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
David B Clemow, Chris Bushe, Michele Mancini, Michael H Ossipov & Himanshu Upadhyaya. (2017) A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities. Neuropsychiatric Disease and Treatment 13, pages 357-371.
Read now
Read now
Shaul Schreiber, Miaad Bader, Vardit Rubovitch & Chaim G. Pick. (2017) Interaction between methylphenidate, methadone and different antidepressant drugs on antinociception in mice, and possible clinical implications. The World Journal of Biological Psychiatry 18:4, pages 300-307.
Read now
Read now
Carl Fleisher & James McGough. (2014) Sofinicline: a novel nicotinic acetylcholine receptor agonist in the treatment of attention-deficit/hyperactivity disorder. Expert Opinion on Investigational Drugs 23:8, pages 1157-1163.
Read now
Read now
Marta Torrens, Paola C. Rossi, Roser Martinez-Riera, Diana Martinez-Sanvisens & Antoni Bulbena. (2012) Psychiatric Co-Morbidity and Substance Use Disorders: Treatment in Parallel Systems or in One Integrated System?. Substance Use & Misuse 47:8-9, pages 1005-1014.
Read now
Read now
Estate Sokhadze, ChristopherM. Stewart, Allan Tasman, Robert Daniels & David Trudeau. (2011) Review of Rationale for Neurofeedback Application in Adolescent Substance Abusers with Comorbid Disruptive Behavioral Disorders. Journal of Neurotherapy 15:3, pages 232-261.
Read now
Read now
Articles from other publishers (65)
Sophie A. Roe, Dayna S. DeSalve & Brian J. Piper. (2023) Analyzing Black Market Sales of the Second-Line ADHD Medication Atomoxetine. Pharmacoepidemiology 2:4, pages 320-327.
Crossref
Crossref
Andreea I. Heriseanu, Dean Spirou, Carlos E. F. Moraes, Phillipa Hay, Rosely Sichieri & Jose C. Appolinario. (2023) Grazing Is Associated with ADHD Symptoms, Substance Use, and Impulsivity in a Representative Sample of a Large Metropolitan Area in Brazil. Nutrients 15:13, pages 2987.
Crossref
Crossref
Leah Davis-Ewart, Ji-Young Lee, Michael Viamonte, Josè Colon-Burgos, Audrey Harkness, Mariano Kanamori, Dustin T. Duncan, Susanne Doblecki-Lewis, Adam W. Carrico & Christian Grov. (2023) “The familiar taste of poison”: a qualitative study of multi-level motivations for stimulant use in sexual minority men living in South Florida. Harm Reduction Journal 20:1.
Crossref
Crossref
Burton Ward, Anees Bahji & David Crockford. (2022) Managing Adult Attention-deficit/Hyperactivity Disorder With Comorbid Substance Use Disorder. Canadian Journal of Addiction 13:4, pages 6-12.
Crossref
Crossref
Philipp Dominik, Martin P. Waßmer, Michael Soyka & Andreas G. Franke. (2022) Stimulant abuse as a coping strategy—Forensic and criminal consequences of stimulant abuse for neuroenhancement. Frontiers in Public Health 10.
Crossref
Crossref
Marius Baranauskas, Ingrida Kupčiūnaitė & Rimantas Stukas. (2022) Potential Triggers for Risking the Development of Eating Disorders in Non-Clinical Higher-Education Students in Emerging Adulthood. Nutrients 14:11, pages 2293.
Crossref
Crossref
Iliyan Ivanov, James M. Bjork, James Blair & Jeffrey H. Newcorn. (2022) Sensitization-based risk for substance abuse in vulnerable individuals with ADHD: Review and re-examination of evidence. Neuroscience & Biobehavioral Reviews 135, pages 104575.
Crossref
Crossref
Wilson Ho & Nathan J. Kolla. (2022) The endocannabinoid system in borderline personality disorder and antisocial personality disorder: A scoping review. Behavioral Sciences & the Law 40:2, pages 331-350.
Crossref
Crossref
Sebastian Skalski, Grzegorz Pochwatko & Robert Balas. (2020) Impact of Motivation on Selected Aspects of Attention in Children with ADHD. Child Psychiatry & Human Development 52:4, pages 586-595.
Crossref
Crossref
Matthew T. Taylor, Daniel B. Horton, Theresa Juliano, Mark Olfson & Tobias Gerhard. (2021) Outpatient prescribing of opioids to adults diagnosed with mental disorders in the United States. Drug and Alcohol Dependence 219, pages 108414.
Crossref
Crossref
Sunsha Chamakalayil, Johannes Strasser, Marc Vogel, Serge Brand, Marc Walter & Kenneth M. Dürsteler. (2021) Methylphenidate for Attention-Deficit and Hyperactivity Disorder in Adult Patients With Substance Use Disorders: Good Clinical Practice. Frontiers in Psychiatry 11.
Crossref
Crossref
Emily Slade, Linda P. Dwoskin, Guo-Qiang Zhang, Jeffery C. Talbert, Jin Chen, Patricia R. Freeman, Kathleen M. Kantak, Emily R. Hankosky, Sajjad Fouladvand, Amy L. Meadows & Heather M. Bush. (2020) Integrating data science into the translational science research spectrum: A substance use disorder case study. Journal of Clinical and Translational Science 5:1.
Crossref
Crossref
David A. Gorelick. 2021. Textbook of Addiction Treatment. Textbook of Addiction Treatment
173
186
.
Molly Minkiewicz, Paul W. Czoty, Bruce E. Blough & Michael A. Nader. (2020) Evaluation of the Reinforcing Strength of Phendimetrazine Using a Progressive-Ratio Schedule of Reinforcement in Rhesus Monkeys. Journal of Pharmacology and Experimental Therapeutics 374:1, pages 1-5.
Crossref
Crossref
G. I. Kovalev, R. M. Salimov, N. A. Sukhorukova, E. A. Kondrakhin & E. V. Vasil’eva. (2020) Neuroreceptor Profile and Behavior of CD-1 Mice Subpopulations with Different Attention Stability. Neurochemical Journal 14:1, pages 13-19.
Crossref
Crossref
Leo Bastiaens, Olivia Scott & James Galus. (2018) Treatment of Adult ADHD without Stimulants: Effectiveness in A Dually Diagnosed Correctional Population. Psychiatric Quarterly 90:1, pages 41-46.
Crossref
Crossref
Fang-Ju Tsai, Wan-Ling Tseng, Li-Kuang Yang & Susan Shur-Fen Gau. (2019) Psychiatric comorbid patterns in adults with attention-deficit hyperactivity disorder: Treatment effect and subtypes. PLOS ONE 14:2, pages e0211873.
Crossref
Crossref
Erin M. Miller, Jorge E. Quintero, Francois Pomerleau, Peter Huettl, Greg A. Gerhardt & Paul E. A. Glaser. (2018) Chronic Methylphenidate Alters Tonic and Phasic Glutamate Signaling in the Frontal Cortex of a Freely-Moving Rat Model of ADHD. Neurochemical Research 44:1, pages 89-101.
Crossref
Crossref
Joseph SadekJoseph Sadek. 2019. Clinician’s Guide to ADHD Comorbidities in Children and Adolescents. Clinician’s Guide to ADHD Comorbidities in Children and Adolescents
61
75
.
Mellessa M. Miller & Helen J.K. Sable. 2018. Handbook of Developmental Neurotoxicology. Handbook of Developmental Neurotoxicology
467
475
.
Oscar G. Bukstein & Aaron Roberto. 2018. Moodiness in ADHD. Moodiness in ADHD
145
159
.
Pieter-Jan Carpentier & Frances R. Levin. (2017) Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us?. Harvard Review of Psychiatry 25:2, pages 50-64.
Crossref
Crossref
Joseph SadekJoseph Sadek. 2017. Clinician’s Guide to Adult ADHD Comorbidities. Clinician’s Guide to Adult ADHD Comorbidities
41
53
.
Marco Solmi, Nicola Veronese, Giuseppe Sergi, Claudio Luchini, Angela Favaro, Paolo Santonastaso, Davy Vancampfort, Christoph U. Correll, Michael Ussher, Nita Thapa-Chhetri, Michele Fornaro & Brendon Stubbs. (2016) The association between smoking prevalence and eating disorders: a systematic review and meta-analysis. Addiction 111:11, pages 1914-1922.
Crossref
Crossref
Michael J. Mason, Alexis Aplasca, Rosa Morales-Theodore, Nikola Zaharakis & Julie Linker. (2016) Psychiatric Comorbidity and Complications. Child and Adolescent Psychiatric Clinics of North America 25:3, pages 521-532.
Crossref
Crossref
P.W. Czoty, B.E. Blough, T.R. Fennell, R.W. Snyder & M.A. Nader. (2016) Attenuation of cocaine self-administration by chronic oral phendimetrazine in rhesus monkeys. Neuroscience 324, pages 367-376.
Crossref
Crossref
Boris B. Quednow & Marcus Herdener. 2016. Neuroscience for Addiction Medicine: From Prevention to Rehabilitation - Methods and Interventions. Neuroscience for Addiction Medicine: From Prevention to Rehabilitation - Methods and Interventions
227
250
.
Marc E. Mooney, David V. Herin, Sheila Specker, David Babb, Frances R. Levin & John Grabowski. (2015) Pilot study of the effects of lisdexamfetamine on cocaine use: A randomized, double-blind, placebo-controlled trial. Drug and Alcohol Dependence 153, pages 94-103.
Crossref
Crossref
Einat Peles, Shaul Schreiber, Shirley Linzy, Yoav Domani & Miriam Adelson. (2015) Differences in Methylphenidate Abuse Rates Among Methadone Maintenance Treatment Patients in Two Clinics. Journal of Substance Abuse Treatment 54, pages 44-49.
Crossref
Crossref
Ike dela Peña, June Bryan de la Peña, Bung-Nyun Kim, Doug Hyun Han, Minsoo Noh & Jae Hoon Cheong. (2014) Gene expression profiling in the striatum of amphetamine-treated spontaneously hypertensive rats which showed amphetamine conditioned place preference and self-administration. Archives of Pharmacal Research 38:5, pages 865-875.
Crossref
Crossref
Christina Nehlin, Fred Nyberg & Caisa Öster. (2014) The Patient’s Perspective on the Link Between ADHD and Substance Use. Journal of Attention Disorders 19:4, pages 343-350.
Crossref
Crossref
Kevin A. Sevarino & Bryan C. Shelby. 2015. Psychiatry. Psychiatry
1561
1614
.
David A. Gorelick. 2015. Textbook of Addiction Treatment: International Perspectives. Textbook of Addiction Treatment: International Perspectives
381
404
.
Ike dela Peña, Hee Jin Kim, Aeree Sohn, Bung-Nyun Kim, Doug Hyun Han, Jong Hoon Ryu, Chan Young Shin, Minsoo Noh & Jae Hoon Cheong. (2014) Prefrontal cortical and striatal transcriptional responses to the reinforcing effect of repeated methylphenidate treatment in the spontaneously hypertensive rat, animal model of attention-deficit/hyperactivity disorder (ADHD). Behavioral and Brain Functions 10:1.
Crossref
Crossref
Einat Peles, Aviv Weinstein, Anat Sason, Miriam Adelson & Shaul Schreiber. (2013) Stroop task among patients with obsessive-compulsive disorder (OCD) and pathological gambling (PG) in methadone maintenance treatment (MMT). CNS Spectrums 19:6, pages 509-518.
Crossref
Crossref
Rolf-Dieter Stieglitz & Maria Hofecker Fallahpour. (2014) Psycho- und Pharmakotherapie bei ADHS und Substanzmissbrauch. DNP - Der Neurologe und Psychiater 15:12, pages 47-56.
Crossref
Crossref
Andreas G. Franke, Christiana Bagusat, Sebastian Rust, Alice Engel & Klaus Lieb. (2014) Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects. European Archives of Psychiatry and Clinical Neuroscience 264:S1, pages 83-90.
Crossref
Crossref
Courtney A. Zulauf, Susan E. Sprich, Steven A. Safren & Timothy E. Wilens. (2014) The Complicated Relationship Between Attention Deficit/Hyperactivity Disorder and Substance Use Disorders. Current Psychiatry Reports 16:3.
Crossref
Crossref
M. Urman-Yotam & M.J. Ostacher. 2014. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Estate M. Sokhadze, David L. Trudeau & Rex L. Cannon. 2014. Clinical Neurotherapy. Clinical Neurotherapy
265
299
.
Joseph SadekJoseph Sadek. 2014. A Clinician’s Guide to ADHD. A Clinician’s Guide to ADHD
63
71
.
Claire Gregorowski, Soraya Seedat & Gerhard P Jordaan. (2013) A clinical approach to the assessment and management of co-morbid eating disorders and substance use disorders. BMC Psychiatry 13:1.
Crossref
Crossref
M. Carmen Carrasco, Jose Vidal & Rosa Redolat. (2013) Bupropion induced changes in exploratory and anxiety-like behaviour in NMRI male mice depends on the age. Behavioural Processes 98, pages 117-124.
Crossref
Crossref
Terje Torgersen, Bjørn Gjervan, Kirsten Rasmussen, Arne Vaaler & Hans M. Nordahl. (2012) Prevalence of comorbid substance use disorder during long-term central stimulant treatment in adult ADHD. ADHD Attention Deficit and Hyperactivity Disorders 5:1, pages 59-67.
Crossref
Crossref
John Leikauf & Iliyan Ivanov. (2013) A Young Man with History of ADHD and Methamphetamine Use. Psychiatric Annals 43:1, pages 26-29.
Crossref
Crossref
Andreas G. Franke & Klaus Lieb. 2013. Cognitive Enhancement. Cognitive Enhancement
17
27
.
Emanuela Giampieri & Massimo ClericiE. di Giacomo, E. Paggi, A. Alamia, E. Giampieri & M. Clerici. 2013. Il suicidio oggi. Il suicidio oggi
177
183
.
Jean-Pierre Chiasson, Katherine Stavro, Élie Rizkallah, Luc Lapierre, Maxime Dussault, Louis Legault & Stéphane Potvin. (2011) Questioning the Specificity of ASRS-v1.1 to Accurately Detect ADHD in Substance Abusing Populations. Journal of Attention Disorders 16:8, pages 661-663.
Crossref
Crossref
Einat Peles, Shaul Schreiber, Agata Sutzman & Miriam Adelson. (2012) Attention Deficit Hyperactivity Disorder and Obsessive-Compulsive Disorder among Former Heroin Addicts Currently in Methadone Maintenance Treatment. Psychopathology 45:5, pages 327-333.
Crossref
Crossref
Pieter-Jan Carpentier. 2012. Drug Abuse and Addiction in Medical Illness. Drug Abuse and Addiction in Medical Illness
285
296
.
E. Sihvola, R. J. Rose, D. M. Dick, T. Korhonen, L. Pulkkinen, A. Raevuori, M. Marttunen & J. Kaprio. (2011) Prospective relationships of ADHD symptoms with developing substance use in a population-derived sample. Psychological Medicine 41:12, pages 2615-2623.
Crossref
Crossref
Louis A. Pagliaro & Ann Marie Pagliaro. 2011. Handbook of Child and Adolescent Drug and Substance Abuse. Handbook of Child and Adolescent Drug and Substance Abuse
371
453
.
David J Houlihan. (2010) Psychostimulant treatment of combat-related posttraumatic stress disorder. Journal of Psychopharmacology 25:11, pages 1568-1572.
Crossref
Crossref
Jan Malat & David A. Kahn. (2011) Clinical Barriers to Effective Pharmacotherapy in Co-occurring Psychiatric and Substance Use Disorders. Journal of Psychiatric Practice 17:5, pages 360-367.
Crossref
Crossref
J Gordon Millichap. (2011) Amphetamine-Associated Seizures. Pediatric Neurology Briefs 25:4, pages 25.
Crossref
Crossref
Roxann C Harvey, Sucharita Sen, Agripina Deaciuc, Linda P Dwoskin & Kathleen M Kantak. (2010) Methylphenidate Treatment in Adolescent Rats with an Attention Deficit/Hyperactivity Disorder Phenotype: Cocaine Addiction Vulnerability and Dopamine Transporter Function. Neuropsychopharmacology 36:4, pages 837-847.
Crossref
Crossref
Thomas E. Wooters, Matthew T. Walton & Michael T. Bardo. (2011) Oral methylphenidate establishes a conditioned place preference in rats. Neuroscience Letters 487:3, pages 293-296.
Crossref
Crossref
Donald E. Greydanus. 2011. Neurodevelopmental Disabilities. Neurodevelopmental Disabilities
111
140
.
A.G. Franke & K. Lieb. (2010) Pharmakologisches Neuroenhancement und „Hirndoping“Pharmacological neuroenhancement and brain doping. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 53:8, pages 853-860.
Crossref
Crossref
Ji Zhang & Jason Crawford. 2010. Modern Drug Synthesis. Modern Drug Synthesis
291
305
.
Sherry A. Ferguson & Sherin Y. Boctor. (2010) Cocaine responsiveness or anhedonia in rats treated with methylphenidate during adolescence. Neurotoxicology and Teratology 32:4, pages 432-442.
Crossref
Crossref
P. A. Woicik, N. Alia-Klein, N. D. Volkow & R. Z. Goldstein. 2009. Imaging in CNS Drug Discovery and Development. Imaging in CNS Drug Discovery and Development
263
289
.
Ester di Giacomo & Massimo Clerici. (2009) Bullismo e disturbo antisociale di personalità in adolescenza ed età giovanile. Quaderni Italiani di Psichiatria 28:3, pages 111-116.
Crossref
Crossref
. (2009) Current World Literature. Current Opinion in Psychiatry 22:3, pages 331-338.
Crossref
Crossref
Jennifer L. Perry, Dustin J. Stairs & Michael T. Bardo. (2008) Impulsive choice and environmental enrichment: Effects of d-amphetamine and methylphenidate. Behavioural Brain Research 193:1, pages 48-54.
Crossref
Crossref